mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-05 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-05 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |